Medication info
Rabehue Tablet 10mg (Rabeprazole Sodium)

Rabehue Tablet 10mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Hybeast Pharmaceutical Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets (14 tablets/AluAlu packaging x 2)
Approval status
Active

MFDS item code 201405520 · Approved 2014.11.25 · Insurance code 628800480

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of 10 mg or 20 mg orally twice daily may be administered. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Symptom relief in gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Ingredients

Manufacturer
Hybeast Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used in the treatment of gastric and duodenal ulcers, for alleviating symptoms of gastroesophageal reflux disease, and for long-term maintenance therapy. It is also used in combination with antibiotics for the treatment of gastrointestinal ulcers caused by Helicobacter pylori infection, and is effective for diseases characterized by excessive gastric acid secretion such as Zollinger-Ellison syndrome. These treatments help reduce damage caused by gastric acid and improve symptoms.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of 10 mg or 20 mg orally twice daily may be administered. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Symptom relief in gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is required. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should receive eradication therapy. Concomitant administration of this drug 20 mg, clarithromycin 500 mg, and amoxicillin 1 g twice daily for 7 days is recommended. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the individual patient's needs. Doses up to 100 mg may be administered once daily; the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Precautions

This drug should not be used in patients with allergies to certain medications or components. Women who are pregnant or breastfeeding should also avoid using this drug. Patients with impaired liver function or the elderly should use this drug with caution, and individuals with a history of allergies should also use it carefully. If allergic reactions such as skin rash or itching occur while taking this medication, discontinue use immediately. It is important to regularly undergo blood tests and liver function tests to check for abnormalities. Symptoms related to the heart or vascular system may occur, so if symptoms appear, consult a medical professional. Mental symptoms, neurological abnormalities, and respiratory symptoms may also occur, so caution is required. Long-term use may increase the risk of bone fractures and lead to electrolyte imbalances such as hypomagnesemia, hence regular monitoring is necessary. This drug strongly inhibits gastric acid secretion, which may slightly increase the risk of bacterial infections in the stomach. Caution is needed as drowsiness or dizziness may occur when driving or operating machinery. Since this drug may interact with other medications, inform your healthcare provider about any other medications you are taking. Do not chew or crush this drug; swallow it whole, and keep it out of the reach of children. There is no specific antidote for overdose; treatment should be symptomatic. Long-term use may result in impaired absorption of vitamin B12, so regular monitoring is required. If symptoms of autoimmune diseases such as systemic lupus erythematosus appear while taking this drug, discontinue use immediately and consult with a specialist. It is recommended to discontinue this medication at least 14 days prior to measuring serum chromogranin A levels for testing.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, increased total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal ECG, migraine, syncope, angina, block of conduction, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stool, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, dysgeusia, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, sialadenopathy, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbances, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, excessive blood volume, limb weakness, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, reduced respiration, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, increased urinary frequency, dysmenorrhea, urinary difficulties, renal stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, heavy menstrual bleeding, orchitis, incontinence, interstitial nephritis, edema, increased total cholesterol, elevated triglycerides, increased BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, phototoxic reactions, hangover effect, weight loss, gout, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, anaphylaxis, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fracture, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, at room temperature between 1 to 30 degrees Celsius. Proper storage will maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets (14 tablets/AluAlu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.